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a dramatic case of pyoderma gangrenosum of unilateral
hand
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Pyoderma gangrenosum (PG) is a cutaneousulcer developing so rapidly that may mimic afulminating infection. The correct treatment is
nonsurgical, and surgery may get the condition worse.1
FK-506 ointment (0.1% Protopic, Astellas Pharma AG,
Fribourg) is usually indicated for inflammatory skin
diseases, such as atopic dermatitis and psoriasis2 or
for acute rejection reversal of human hand transplanta-
tion 3. A few reports of PG affecting the functions of hands
can be found in the scientific literature and this report
describes the first case treated by FK-506 ointment as
an adjuvant therapy.
CASE REPORT
A 67-year-old right-handed man was admitted to our
Institution with reddish-bluish skin and painful pustules
growing on the dorsal sides of the proximal phalanxes
of the index and middle fingers. A minor trauma made
by a kitchen-knife two weeks before preceded the ap-
pearance of the lesions. No associated systemic dis-
ease was found in our patient. The routine blood tests
on admission revealed that the white cells were counted
for 12.7×109/L,  haemoglobin for 14.0 g/dl, C-reactive
protein for 55 mg/l, and erythrocyte sedimentation rate
(ESR) for 14.
A misdiagnosis of necrotizing fasciitis was made,
so according to the infectious disease, service of full
doses of antibiotic therapy through intravenous injec-
tion was started with 600 mg Clindamycin three times
per day plus 500 mg Ciprofloxacin twice a day at the
beginning (six days) then combining with 500 mg
Imipenem four times per day. Meanwhile, three uneventful
sequential surgical debridments were made. All cultures
taken from the lesions were negative. After 7 days, no
clinical improvement was detected in spite of aggres-
sive surgical and antibiotic care (Fig. 1). However, new
pustules grew rapidly on the ulnar side of the hand and
on the dorsal side of the thumb and on the metacar-
pophalangeal (MP) joint. We consulted our dermatolo-
gist and the diagnosis of PG was immediately consid-
ered based on the necrotic fingers failing to improve
with multiple debridments, broad antibiotic coverage and
multiple negative cultures. Findings of a skin biopsy
with the specimen taken from the proximal phalanx of
the index finger confirmed the diagnosis of PG, a bul-
lous variant.
Histological examination showed a necrotic suppu-
rating process involving the dermis and the deep sub-
cutis (subepidermal edema with bulla formation). Nu-
merous polymorph neutrophils were detected in the
dermal layer, which was accompanied by epidermal
hyperplasia. On the contrary, no signs of vasculitis were
shown (Fig. 2).
Antibiotic therapy was then stopped and 40 mg pred-
nisone daily combined with FK-506 ointment (Protopic
0.1%, Astellas Pharma AG, Fribourg) twice a day was
administered for the first three weeks. Protopic was
applied in one thin layer only in the areas of the skin
affected by PG to avoid sun exposure and no bandages,
dressings or wraps being used for covering the skin. At
this stage, full-thickness skin loss on the dorsal side of
Case reports
Chinese Journal of Traumatology 2009; 12(3):181-183. 182 .
the index and middle fingers, on the dorsal side of the
thumb, on the MP joint and on the ulno-volar side of the
hypothenar eminence was clear. In only 72 hours, all
reddish and bluish pustules got pinker and smaller and
granulation tissues grew really rapidly (Fig. 3A). A
colonscopy excluded Cronh’s disease or regional en-
teritis and specific blood tests excluded rheumatoid
arthritis, chronic active hepatitis, myeloproliferative
disorders, iron deficiency anemia, myeloma, leukae-
mia and diabetes mellitus. Oral prednisone was pro-
gressively tapered and steroid + FK506 ointment (once
a day from Week 3 to Week 12) were stopped after
three months with complete “restitution ad integrum”
either aesthetically or functionally (Fig. 3B). Neither lo-
cal skin burning/pruritus nor general side effects relat-
ing to the use of the ointment were detected 6 months
after complete resolution of all symptoms.
Fig.1. Progressively-grown pustules in spite of surgical debridment on the right hand before starting prednisone + FK-506-ointment
therapy. A: Five days after admission; B: Seven days after admission.
Fig. 2. Bioptic examination of pyoderma gangrenosum (PG), a bullous variant. A: Dermal massive neutrophilic infiltration (HE x10); B:
Dermal neutrophils with abscess formation and no signs of vaculitis (HE x 40).
Fig. 3. A: Clinical appearance of the hand 72 hours after prednisone + FK-506-ointment therapy. B: Clinical appearance of the hand after
5 months of follow-up.
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DISCUSSION
This case confirmed the typical characteristics of
PG with a painful red pustule rapidly enlarging and be-
coming necrotic and ulcerating, resistant to antibiotic
therapy and surgical debridments. All cultures were
negative and correct diagnoses were made thanks to
clinical findings made by a dermatologist and histo-
logic examination. Surgical procedures (debridments
and/or skin grafts) are contraindicated.4,5
Historical management of PG consists of local
wound care, treatment of associated medical condi-
t ions and oral  administrat ion of  high-dose
corticosteroids (prednisone, 100 md/day).6  PG re-
sponds also to oral dapsone,  7 azathioprine,  5
cyclosporin,  8 clofazimine or sulfasalazine 9 or
intralesional steroid injections.10  FK-506 ointment is a
calcineurin inhibitor usually indicating for chronic treat-
ment of atopic dermatitis and psoriasis2 or for acute
rejection reversal of human hand transplantation3. We
therefore confirm the safety and effectiveness of FK-
506 ointment adjuvant therapy, which is also useful in
reducing the recommended doses of steroid and length
of therapy and avoiding inappropriate surgical therapy.
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